Cholestaway cholesterol binding, elimination claims prohibited under FTC settlement.
This article was originally published in The Tan Sheet
Executive Summary
CHOLESTAWAY CHOLESTEROL BINDING CLAIMS SUBJECT TO FTC SETTLEMENT with the product's marketer, Bogdana Corp., and its principles, Joseph and Bogda Gruber, released by the Federal Trade Commission May 12. Ad claims at issue in the case include statements that Cholestaway prevents fat from being absorbed and "does the same thing with cholesterol. It combines with it. One molecule of Cholestaway will bind two molecules of fat or two molecules of cholesterol." Cholestaway causes fat to "go right through you," the ad says, claiming fat in the diet "would actually become part of the stools and it would be eliminated." Cholestaway consists of wafers said to contain calcium and magnesium.